| Caleb Duff, | |
|
414 Industrial Park Road, Maxwelton, WV 24957 | |
| (304) 497-2850 | |
| Not Available |
| Full Name | Caleb Duff |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 414 Industrial Park Road, Maxwelton, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184494163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 40809 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Caleb Duff, Po Box 134, Alderson, WV 24910-0134 Ph: () - | Caleb Duff, 414 Industrial Park Road, Maxwelton, WV 24957 Ph: (304) 497-2850 |
News Archive
In one of the largest adult vaccine clinical trials ever, researchers have found that an experimental vaccine against shingles (zoster vaccine) prevented about half of cases of shingles-a painful nerve and skin infection-and dramatically reduced its severity and complications in vaccinated persons who got the disease. The findings appear in the June 2 issue of The New England Journal of Medicine.
In a new study of breast milk and store-bought milk from across the United States, scientists at Texas Tech University found perchlorate in every sample but one. The results suggest that this thyroid-disrupting chemical may be more widespread than previously believed.
Researchers at The University of Texas Health Science Center at Houston plan to launch a clinical study looking at complication rates in patients who have experienced severe trauma to the abdominal area and require immediate surgery to diagnose and treat the injuries at Memorial Hermann-Texas Medical Center.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has contracted with the clinical research organization (CRO) Averion International Corp. to conduct its planned Phase II study of ICT-107, the Company's lead cancer-vaccine candidate for the treatment of glioblastoma multiforme (GBM).
Researchers in the United States have developed a novel protein that prevented lethal disease among mice infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 2 days ago
Sahrah Michelle Elswick, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 804 Industrial Park Rd, Maxwelton, WV 24957 Phone: 888-736-3229 | |
Cassi Vannatter, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 804 Industrial Park Rd, Maxwelton, WV 24957 Phone: 304-497-0500 Fax: 304-497-0516 | |
Mrs. Ashley Renee Mandeville, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 804 Industrial Park Rd, Maxwelton, WV 24957 Phone: 304-497-0500 Fax: 304-497-0516 |